|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/352 | |
| A61P 1/16 | |||
| A61P 13/12 | |||
| A61P 17/00 | |||
| A61P 11/00 | |||
| A61P 21/00 | |||
| A61P 29/00 |
| (11) | Patento numeris | 2717692 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12796691.9 |
| Europos patento paraiškos padavimo data | 2012-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/040380 |
| Data | 2012-06-01 |
| (87) | Numeris | WO 2012/170290 |
| Data | 2012-12-13 |
| (30) | Numeris | Data | Šalis |
| 201161493435 P | 2011-06-04 | US | |
| 201213485044 | 2012-05-31 | US |
| (72) |
ZURIER, Robert, B., US
SELVI, Enrico, IT
|
| (73) |
Corbus Pharmaceuticals, Inc.,
100 River Ridge Drive, Norwood, MA 02062,
US
|
| (54) | TETRAHYDROCANNABINOL-11-OIC ACIDS FOR USE IN TREATING FIBROTIC DISEASES |
| TETRAHYDROCANNABINOL-11-OIC ACIDS FOR USE IN TREATING FIBROTIC DISEASES |